Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
New hope for long-COVID patients: Longidaza boosts exercise tolerance and improves pulmonary function.
Sponsored
The future of third-party logistics in an evolving biopharmaceutical world
A novel, toothy approach to innovating randomization in clinical trials
Building up the infrastructure for future pandemic preparedness: Frontiers in rapid raw material production
Transforming preventative care in the NHS
The Innovations Shoring Up Clinical Supply Chain Integrity in the Age of Advanced Therapies
Innovative Buffer Management Solutions: ZETA’s Modular Buffer Inline Conditioning System
All-in-one milling platforms: How to reduce your machinery footprint
